Drug Shortage Report for AURO-PRAVASTATIN
Report ID | 93099 |
Drug Identification Number | 02458977 |
Brand name | AURO-PRAVASTATIN |
Common or Proper name | Pravastatin Sodium |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | PRAVASTATIN SODIUM |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-09-04 |
Estimated end date | 2019-12-30 |
Actual end date | 2019-12-19 |
Shortage status | Resolved |
Updated date | 2019-12-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2019-12-20 | French | Compare |
v7 | 2019-12-20 | English | Compare |
v6 | 2019-11-11 | French | Compare |
v5 | 2019-11-11 | English | Compare |
v4 | 2019-10-21 | French | Compare |
v3 | 2019-10-21 | English | Compare |
v2 | 2019-09-05 | French | Compare |
v1 | 2019-09-05 | English | Compare |
Showing 1 to 8 of 8